Global Gene Expression Analysis Market - 2022-2029

Market Overview

Gene Expression Analysis Market size was valued US$ 4.1 billion in 2021 and is estimated to reach US$ 9.5 billion by 2029, growing at a CAGR of 11.2% during the forecast period (2022-2029).

Gene expression analysis is the study of how genes are transcribed to synthesize functional gene products, functional RNA species, or protein products. The study of gene regulation provides insights into normal cellular processes, such as differentiation and abnormal or pathological processes.

Market Dynamics

The rising R&D initiatives, development of genomic databases, increased government funding and growing awareness towards personalized medicine is driving the market's growth over the forecast period.

Increasing advancements such as NGS or molecular services and rising government fundings are expected to drive market growth.

The global gene expression analysis market growth is driven by several factors, such as personalized medicine is becoming more popular with the growing number of genetic disorders. Also, growing awareness towards personalized medicine is driving the market's growth over the forecast period.

The growing technological advancement such as NGS and molecular services are boosting the demand for gene expression services. Additionally, the development of genomic databases, increased government funding towards genomics, and personalized medicine growth are likely to drive the market. Increasing government funding towards genomics is one of the major factors leading to the gene expression analysis market growth.

Genomics research is driven by government and non-profit funding sources, augmented by private research and development (R&D) funding. The National Human Genome Research Institute (NHGRI) funds and collaborates with scientists in government, public and private institutions.

Citizens and taxpayers of several countries have funded much of the research and have expectations about access to the resulting information and knowledge. While access to knowledge gained from all publicly funded research is desired, access is essential for fields that have broad social impact and stimulate public dialogue.

Genomics is a field where public concerns are raised for health care and insurance implications and personal and ancestral identification. Thus, genomics has grown rapidly as a field and attracts considerable interest.

High cost associated with gene expression analysis is expected to hamper the market growth.

Factors such as the high cost of instruments and lack of skilled labor are expected to hinder the market's growth over the forecast period.

Industry Analysis

The global gene expression analysis market provides in-depth analysis of the market based on various industry factors such as Porter's Five Forces, Regulatory and Reimbursement Analysis, Supply Chain Analysis, Pricing Analysis, Competitive Scenario, Product Innovation, Unmet Needs.

Segment Analysis

Next generation sequencing segment is expected to hold the largest market share in global gene expression analysis market

The next-generation sequencing market (NGS), also known as high throughput sequencing, is a technology through which millions of DNA strands are sequenced by massive parallelization. NGS offers several advantages over other techniques: high accuracy, low cost, fast speed, and precise results even from low sample input. Hence, it is used to execute various applications, such as biomarker discovery, oncology studies, personalized medicine, and agricultural and animal research.

NGS is used to diagnose various illnesses, such as cancer, hematological disorders, neurology, psychiatry, dysmorphology, vision and hearing impairment, cardiology, and pharmacogenomics. It is also used as a tool for non-invasive prenatal tests. NGS technology can be used for large-scale SNPs screening to determine if a drug candidate will be effective and safe. Next-generation sequencing can help change DNA sequencing and genetic characterization used in drug discovery and drug development.

In November 2019, QIAGEN announced expanding its QIAseq NGS portfolio to offer a one-day workflow for simultaneous preparation of DNA and RNA libraries using next-generation sequencing (NGS) technologies. The new QIAseq Multimodal Panels are the only solution to offer a consolidated workflow to simultaneously detect DNA variants, RNA fusions, and gene expression levels from a single sample, with input as low as 10 ng of total nucleic acid.

Geographical Analysis

North America region holds the largest market share in the global gene expression analysis market

North America is dominating the global gene expression analysis market, with the United States accounting as the major contributor to the market. The United States spends the most compared to other countries on genomics research, corresponding to 40% of worldwide public funding.

Citizens and taxpayers of several countries have funded much of the research and have expectations about access to the resulting information and knowledge. While access to knowledge gained from all publicly funded research is desired, access is essential for fields that have broad social impact and stimulate public dialogue. Innovate UK has up to £5 million to support capital investment in equipment that increases the UK's capacity to produce and commercialize genomic analysis technologies.

Most of the major key players are based in North America such as Illumina, Inc., Quest Diagnostics Incorporated, Bio-Rad Laboratories, Thermo Fisher Scientific, Inc., Agilent Technologies, Luminex Corporation etc are contributing in making this region the largest shareholder in gene expression analysis market.

In Jan 2022, Illumina Inc. announced a multi-year agreement with Nashville Biosciences LLC to increase medicines development via large-scale genomics and also the formation of clinical-genomic resource that is pre-eminent with the help of Illumina's next-generation sequencing (NGS).

Competitive Landscape

The global gene expression analysis market is highly fragmented with the presence of a large number of international and local players. Some of the market's major players include QIAGEN, Illumina, Inc., Quest Diagnostics Incorporated, Bio-Rad Laboratories, Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Inc., Novogene Corporation, Agilent Technologies, PerkinElmer Inc., Promega Corporation, Luminex Corporation., among others.

The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of the gene expression analysis market globally. For instance,

In September 2019, QIAGEN launched its newly enhanced GeneGlobe Design & Analysis Hub, bringing next-level experiment planning, execution, and follow-up to life science researchers.

In June 2019, Singapore-based Proteona Pte. Ltd. launched the ESCAPE proteogenomics assay designed specifically for Chimeric Antigen Receptor (CAR) T cell characterization. This is the first commercial product designed to characterize RNA and protein expression levels across thousands of single CAR T cells.

Key Companies to Watch

QIAGEN:

Overview: Qiagen a German company that develops sample and assay technologies used for molecular testing and diagnostics, and biopharma research. It was founded in 1984 and is headquartered in Hilden, Germany. Their products and services are being provided in around 25 countries.

Product Portfolio:

RT2 Profiler PCR Arrays: It is a quick and authentic gene expression analysis of around 170+ pathways that helps researchers by reducing time at the bench and provides more time for interpreting the results. These are laboratory-verified qPCR assays that are path-focused panels, with combined and patented controls for conducting a successful experiment.

Key Developments: In Sep 2020, Qiagen and NeuMoDx in partnership are manufacturing and marketing two fully integrated automated PCR devices.

The global gene expression analysis market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.